|
American Way - September 1, 2009
Cultivating Second Chances
Cambridge, MA - May 27, 2009
CombinatoRx Reports Positive Phase 2 Trial Results for CRx-401
Cambridge, MA - May, 6, 2009
CombinatoRx Announces Oncology Collaboration with Novartis
Lexington, MA - April 7, 2009
EPIX Pharmaceuticals Commences Exchange Offer for $100 Million Convertible Notes
Lexington, MA - March 17, 2009
EPIX Pharmaceuticals Issued Composition of Matter Patent on Novel 5-HT4 Receptor Agonists
Lexington, MA - March 5, 2009
EPIX Pharmaceuticals Appoints Elkan Gamzu, Ph.D., as Permanent CEO
Cambridge, MA - January 28, 2009
CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate
Atlanta, GA - January 12, 2009
GaBio Names Grace Powers, Emerging Leader of the Year
Cumberland, RI - January 8, 2009
Collegium Pharmaceutical Announces FDA Approval of AllerNaze™, a Nasal Inhaled Steroid for the Treatment of Allergic Rhinitis
Lexington, MA - December 22, 2008
EPIX Pharmaceuticals Announces FDA Approval of Vasovist(R) (gadofosveset trisodium)
Cambridge, MA - December 9, 2008
CombinatoRx Presents New Data on B-Cell Malignancy Programs
Cambridge, MA - October 6, 2008
CombinatoRx Announces Top-Line Results from Phase 2b Study of Synavive(TM) (CRx-102) for Knee Osteoarthritis
Lexington, MA - September 16, 2008
EPIX Pharmaceuticals Achieves Milestone from Collaboration with Cystic Fibrosis Foundation Therapeutics
Waltham, MA - September 2, 2008
Histogenics Secures $9 Million in Second Round of Financing
Lexington, MA - August 5, 2008
Financing Facility May Provide EPIX Up To $50 Million of Capital
MarketWatch - July 29, 2008
New Hope for Alzheimer's Patients
Cambridge, MA - July 23, 2008
CombinatoRx Highlights Progress in Key Programs at 2008 R&D Day
Cumberland, RI - July 16, 2008
Collegium Pharmaceutical Announces U.S. Patent Issued Covering its DETERx™ Abuse Deterrent Sustained Release Technology
Cumberland, RI - July 15, 2008
Collegium Pharmaceutical Announces Completion of Series D Financing
Franklin, MA - June 23, 2008
Arthrosurface Receives CE Mark Approval for Uni Knee Resurfacing System
Lexington, MA - June 11, 2008
EPIX Pharmaceuticals Initiates Second Trial in Phase 2b Program for Alzheimer's Disease
Lexington, MA - June 5, 2008
EPIX Pharmaceuticals Achieves Milestone For Third Discovery Program in Collaboration with GlaxoSmithKline
Chicago Tribute Web Edition - June 3, 2008
Staying active with toe implant
Waltham, MA - May 30, 2008
Histogenics Appoints Ken Andrews President and CEO
Atlanta, GA - March 20, 2008
DCA Life Sciences Facilities Fund Program Completes $2M Loan to CardioMEMS
Cambridge, MA - March 12, 2008
CombinatoRx Drug Candidate CRx-191 Demonstrates Positive Phase 2 Results in Psoriasis
Cambridge, MA - February 26, 2008
CombinatoRx Granted Broad Patent Covering TCA-Glucocorticoid Combinations
Bridgewater, NJ - February 12, 2008
Sapphire Therapeutics Promotes Suzan Allen to Vice President Clinical Operations
Cambridge, MA - January 24, 2008
CombinatoRx Provides Goals and Guidance for 2008
Lexington, MA - January 23, 2008
EPIX Pharmaceuticals Achieves $1.25 Million Milestone in Collaboration with Cystic Fibrosis Foundation Therapeutics
Cumberland, RI - December 6, 2007
Onset Therapeutics Announces FDA Submission for Novel Product for Topical Treatment of Genital Warts
Atlanta, GA - December 4, 2007
CardioMEMS, Inc. Closes $33 Million Series E Financing and Appoints New CFO
Lexington, MA - November 12, 2007
EPIX to Raise $16.3 Million through Private Financing
Cambridge and South Egremont, MA - November 8, 2007
CombinatoRx and Charley's Fund/Nash Avery Foundation Collaborate to Develop Novel Agents for Duchenne Muscular Dystrophy
Lexington, MA - November 5, 2007
EPIX Pharmaceuticals Achieves Milestone For Second Discovery Program in Collaboration with GlaxoSmithKline
Cumberland, RI - October 31, 2007
Collegium Pharmaceutical Inc. Announces Successful Completion of Proof of Concept Study for its Abuse Deterrent Sustained Release Opioid Product
Lexington, MA - October 29, 2007
EPIX Pharmaceuticals Reports Preliminary Findings from Phase 1b Clinical Trial of Novel 5-HT6 Drug Candidate
Lexington, MA - October 25, 2007
EPIX Pharmaceuticals Completes Enrollment in Two Key Clinical Trials
Cambridge, MA - October 25, 2007
CombinatoRx Publishes Clinical Study Results of CRx-102 in Hand Osteoarthritis
Cambridge, MA - October 22, 2007
CombinatoRx Receives Huntington's Disease Society Leadership Award
Cambridge, MA - October 11, 2007
CombinatoRx Announces Registered Direct Common Stock Offering of $35 Million
Cambridge, MA - September 26, 2007
CombinatoRx Announces Initiation of Phase 2b Clinical Study of CRx-102 in Knee Osteoarthritis
Waltham, MA - September 26, 2007
Histogenics NeoCart Cartilage Therapy Found Promising in OHSU Study
Atlanta, GA – September 13, 2007
CardioMEMS Announces Start of CHAMPION Pivotal Study of Wireless Pressure Sensing for Heart Failure Monitoring
Atlanta, GA - September 13, 2007
CardioMEMS Announces Start of CHAMPION Pivotal Study of Wireless Pressure Sensing for Heart Failure Monitoring
Lexington, MA - August 28, 2007
EPIX Pharmaceuticals Achieves Milestone in Collaboration with Cystic Fibrosis Foundation Therapeutics
Cumberland, RI - August 15, 2007
Collegium Pharmaceutical Provides Update on Development of its Nasal Inhaled Steroid for Allergic Rhinitis
Cambridge, MA - August 14, 2007
CombinatoRx Announces Initiation of Phase 2a Proof-of-Concept Clinical Study with CRx-401 for Type 2 Diabetes
Lexington, MA - August 14, 2007
EPIX Pharmaceuticals Achieves Discovery Milestone in Collaboration with GlaxoSmithKline
Bridgewater, NJ - August 9, 2007
Sapphire Therapeutics Announces Promotions and New Appointment to Management Team
Lexington, MA - August 7, 2007
EPIX Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial
Cumberland, RI - July 12, 2007
Collegium Pharmaceutical Inc. Announces FDA Acceptance of IND for its Abuse Deterrent Sustained Release Opioid Product
Cambridge, MA - June 4, 2007
CombinatoRx Adds Sally W. Crawford and W. James O'Shea to Its Board
Waltham, MA - May 21, 2007
Histogenics Names Bernitz President and Chief Executive Officer
Cambridge, MA - May 16, 2007
CombinatoRx Selected to Join NASDAQ Biotechnology Index
Lexington, MA - May 2, 2007
EPIX Announces Retirement of Christopher Gabrieli as Chairman of the Board of Directors
Lexington, MA - April 18, 2007
http://investor.epixpharma.com/phoenix.zhtml?c=91717&p=irol-newsArticle&ID=984307&highlight=
Cambridge, MA - April 17, 2007
CombinatoRx Announces the Identification of Synergistic Enhancers of TRAIL-Mediated Apoptosis
Lexington, MA - April 12, 2007
EPIX Regains Compliance with NASDAQ, Files Form 10-K
Lexington, MA - March 29, 2007
EPIX Pharmaceuticals Initiates Phase 2b Clinical Trial of PRX-00023 in Patients with Major Depressive Disorder
Atlanta, GA - March 28, 2007
CardioMEMS, Inc. Announces FDA Clearance of the EndoSure™ Wireless AAA Pressure Measurement System for Measuring Intrasac Pressure During TAA Repair
Bridgewater, NJ - March 27, 2007
Sapphire Therapeutics Promotes William Polvino to CEO, Herb Conrad Elected Chairman of the Board
Cambridge, MA - March 26, 2007
CombinatoRx Provides Topline Results from Phase 2 RA Study with CRx-139 and Very Low Dose Prednisolone
Atlanta, GA - March 22, 2007
CardioMEMS, Inc. Announces First Patient Implant of Wireless Pressure Sensor for Hypertension Monitoring
Cumberland, RI - March 5, 2007
Collegium Announces Successful Completion of Allergic Rhinitis Product Trial
Atlanta, GA - January 24, 2007
CardioMEMS Files for IPO
Atlanta, GA - January 23, 2007
CardioMEMS wins 2007 Deal of the Year award
Lexington, MA - January 3, 2007
EPIX Pharmaceuticals Secures Patent on Novel 5-HT1A Receptor Agonist and the Treatment of Disorders Associated with Serotonin Action
London, Philadelphia & Lexington, MA - December 12, 2006
GlaxoSmithKline and EPIX Pharmaceuticals Enter Drug Discovery and Development Alliance
Lexington, MA - December 7, 2006
EPIX Pharmaceuticals Presents Findings from PRX-08066 Clinical Trials at National Institutes of Health Pulmonary Hypertension Meeting
Lexington, MA - December 5, 2006
EPIX Pharmaceuticals Initiates Phase 2a Clinical Trial in Patients with Mild Alzheimer's Disease
Portland, OR - November 28, 2006
OHSU Doctors Test Disc to Repair Knee Cartilage Damage
Franklin, MA - November 27, 2006
More Than 1,000 Patients Receive the Arthrosurface Product for the Great Toe
Cambridge, MA - November 6, 2006
CombinatoRx Drug Candidate CRx-102 Demonstrates Positive Phase 2 Results in Rheumatoid Arthritis
Atlanta, GA - November 1, 2006
CardioMEMS, Inc. Closes $22.6 Million Series D Financing and Appoints New CFO
Bridgewater, NJ - October 26, 2006
Sapphire Therapeutics, Inc. Licenses Novel Drug to Ono Pharmaceuticals in Japan, Korea and Taiwan for the Treatment of Cancer Anorexia/Cachexia
Lexington, MA - October 24, 2006
EPIX Pharmaceuticals Initiates Phase 1 Multiple Ascending Dose Clinical Trial of PRX-07034 in Obesity
Lexington, MA - October 17, 2006
EPIX Pharmaceuticals Announces Findings from Obesity and Cognitive Impairment Studies at Society for Neuroscience Meeting
Cumberland, RI - October 4, 2006
Collegium Pharmaceutical Inc., Announces FDA Acceptance of IND for Novel Combination Allergic Rhinitis Product
Franklin, MA - October 3, 2006
Arthrosurface Patients Cross the Three Year Mark
Lexington, MA - Sept. 20, 2006
EPIX Announces Australian Approval of Vasovist(TM)
Bridgewater, NJ - September 19, 2006
Sapphire Therapeutics, Inc. Licenses Ghrelin Mimetic from Novo Nordisk Lpamorelin to Enter Phase II for Postoperative Ileus
Bridgewater, NJ - August 25, 2006
Sapphire Therapeutics, Inc. Expands Team
Boston, MA - August 22, 2006
Boston Millennia Partners Invests in Histogenics Corporation
Lexington, MA - August 16, 2006
EPIX and Predix Pharmaceuticals Complete Merger
Franklin, MA - August 14, 2006
Arthrosurface Launches New Product for Treatment of Patello-Femoral Disease
Cambridge, MA - June 29, 2006
CombinatoRx to Be Included in Russell 3000 Index
Cambridge, MA - June 22, 2006
CombinatoRx Drug Candidate CRx-102 Demonstrates Statistically Significant Improvement in Pain and Other Clinical Measures
Boston, MA - June 9, 2006
Merck & Co., Inc. Acquires GlycoFi, Inc. for $400 Million
Cumberland, RI - June 6, 2006
Collegium Pharmaceutical Announces the Achievement of Development Milestone Under the Agreement with Cypress Bioscience
Cambridge, MA - June 5, 2006
CombinatoRx Appoints Michael Kauffman, MD, PhD to Its Board of Directors
Atlanta – June 1, 2006
CardioMEMS, Inc. Announces First Human Use of Wireless Pressure Sensors in the Left Atrium of the Heart.
Cambridge, MA & Bethesda, MD - June 1, 2006
CombinatoRx & Cystic Fibrosis Foundation Therapeutics Enter into a Collaboration to Develop Novel Therapeutics
Cambridge, MA - May 22, 2006
CombinatoRx Reports Second Positive Phase 2 Study with CRx-102
Cambridge, MA - April 24, 2006
CombinatoRx Appoints Lynn Baird, Ph.D., as Senior Vice President of Regulatory Affairs, QA/QC
Cambridge, MA & Singapore - April 21, 2006
CombinatoRx Receives Infectious Disease Research Grant Approval from Singapore's Economic Development Board
Lexington, MA - April 19, 2006
Predix Announces Preliminary Results from Phase Ib Trial of PRX-08066 in Hypoxia-Induced Pulmonary Hypertension
Cambridge, MA - April 18, 2006
CombinatoRx Reports Positive Results for CRx-170 in Phase 2 Proof-of-Concept Asthma Clinical Trial
Cambridge and Lexington, MA - April 3, 2006
Epix and Predix Announce Merger Agreement
Cambridge, MA - April 3, 2006
CombinatoRx Announces Discovery of Novel Synergistic Combination Leads for Glioblastoma
Atlanta, GA - March 31, 2006
CardioMEMS, Inc. Wins Frost & Sullivan 2006 Product Innovation of the Year Award
Boston, MA - March 23, 2006
CombinatoRx Announces $48.0 Million Private Placement
Atlanta – February 20, 2006
CardioMEMS, Inc. Announces First Human Use of Wireless Pressure Sensor for Congestive Heart Failure Monitoring
Boston, MA - January 30, 2006
CombinatoRx Drug Candidate CRx-102 Demonstrates Positive Phase 2 Study Results in Hand Osteoarthritis
Bridgewater, NJ - January 17, 2006
Sapphire Therapeutics, Inc. Appoints New Director and Creation of a Scientific Advisory Board
Atlanta, GA - January 9, 2006
CardioMEMS Names Matt Borenzweig Vice President of Sales
Bridgewater, NJ - January 6, 2006
Sapphire Therapeutics, Inc. Builds Drug Development Team through New Hires and Promotion
Atlanta, GA - December 14, 2005
CardioMEMS Closes Series C Financing
Lebanon, NH - December 12, 2005
GlycoFi and Merck & Co., Inc. Enter into Broad Strategic Alliance for Research and Development
Forbes.com - December 12, 2005
Pharma's Little Helper
Tampa, FL. - December 6, 2005
Accentia Biopharmaceuticals Acquires Exclusive License for an Additional Late-Stage Respiratory Product
Boston, MA - November 14, 2005
CombinatoRx Completes IPO
Boston, MA - November 9, 2005
CombinatoRx, Incorporated Announces Pricing of Its Initial Public Offering
Atlanta - November 1, 2005
CardioMEMS, Inc. Announces 510(k) Clearance and U.S. Launch of the EndoSure™ Wireless AAA Pressure Measurement System
Lebanon, NH - October 10, 2005
Glycofi Closes Oversubscribed $11 Million Venture Round
Bridgewater, NJ - October 5, 2005
Rejuvenon Corporation Changes Name to Sapphire Therapeutics
BOSTON, MA – October 3, 2005
CombinatoRx and Angiotech Pharmaceuticals Sign Agreement
Cumberland, RI - August 25, 2005
BTG and Collegium Pharmaceutical to Develop a Modified Release Asthma Product
Cumberland, RI - July 26, 2005
Collegium Pharmaceutical Inc., Announces the Launch of Exactacain™
Boston, MA and Taipei, Taiwan - July 18, 2005
CombinatoRx Licenses CRx-026 Territory Rights to HenKan Pharmaceutical
Woburn, MA - May 3, 2005
Predix Pharmaceuticals Initiates Phase I Clinical Trial of 5-HT2B Receptor Antagonist for Pulmonary Hypertension
Cumberland, RI - (BUSINESS WIRE) - April 20, 2005
Collegium Pharmaceutical Inc. and United Research Laboratories/Mutual Pharmaceutical Company Announce Product Development Agreement
Boston, MA - April 13, 2005
CombinatoRX Receives $4.4 Million Grant from the National Institute of Allergy and Infectious Diseases
Mass High Tech - April 11, 2005
Biomed Rounds: PHT makes its mark in drug-trial patient diaries
Woburn, MA - March 30, 2005
Predix Pharmaceuticals Initiates Phase Ib Clinical Trials Of 5-HT4 Agonist For Alzheimer’s Disease And Other Cognitive Disorders
Woburn, MA and Bethesda, MD - March 16, 2005
Cystic Fibrosis Foundation Therapeutics and Predix Pharmaceuticals Announce Drug Discovery Collaboration to Treat Cystic Fibrosis
Woburn, MA - March 8, 2005
Predix Pharmaceuticals Announces Initiation of Phase II Clinical Trial of its Serotonin 1A Agonist for Generalized Anxiety Disorder
Milpitas, CA and Charlestown, MA - February 23, 2005
palmOne and PHT Declare Record Year with 20,000 Handheld eDiaries Deployed for Use in Clinical Trials
Atlanta, GA - February 21, 2005 - The Whistle
Clinical trials move heart sensors one step closer to commercialization
Charlestown, MA - February 15, 2005
PHT Corporation Strengthens ePRO Market Dominance with Record Year in 2004
FRANKLIN, MA - February 10, 2005
Boston Millennia Partners Leads $10.5 million Fourth Round of Preferred Equity Financing in Arthrosurface.
Palo Alto, Ca - February 7, 2005
Coapt Systems Launches ENDOTINE® Triple™
Boston, MA - January 25, 2005
Boston Millennia Partners Announces the Sale of Portfolio Company Yantra Corporation
Boston, MA – January 25, 2005
Boston Millennia Partners Co-Leads a $43 million Series C in Predix Pharmaceuticals
Charlestown, MA - January 13, 2005
Greer Selects PHT’s LogPad System for Phase I Sublingual-Oral Immunotherapy Trials
Cumberland, RI - (BUSINESS WIRE) - January 4, 2005
Collegium Pharmaceutical Inc., HEALTHPOINT, Ltd Announce Licensing Agreement for Two Late Stage Products
Charlestown, MA - November 17, 2004
Orphan Medical Relies on PHT LogPad® for Phase II Fibromyalgia Trial
Boston, MA and Burlingame, CA - Sept. 27, 2004
CombinatoRx and ABC2 Initiate Brain Cancer Collaboration
September 17, 2004 - New York, NY - The Journal News
Doctors Test an "E-ZPass" For the Chest
Boston, MA and New York, NY - VENTURE WIRE - September 13, 2004
CombinatoRx Signs Discovery Deal With Spinal Muscular Atrophy Foundation
Charlestown, MA –- July 13, 2004
PHT LogPad® Chosen by Rinat Neuroscience for First In-human Trial
Cumberland, RI - (BUSINESS WIRE) - June 17, 2004
Collegium Pharmaceutical Inc. Receives Notice of Allowance from U.S. Patent and Trademark Office for Novel Anti-Histamine Combination
Tewksbury, MA - June 16, 2004
Inbound Logistics Recognizes Yantra as a Top 100 Logistics IT Provider
Redmond, WA - June 14, 2004
AT&T Wireless Helps Open Up World To PHT
Atlanta, GA - April 2, 2004
CardioMEMS, Inc. Announces First Human Use of its Implantable Sensor Technology
Boston, MA – March 25, 2004
Boston Millennia Partners Leads $6M Round in ArthroSurface
Boston, MA – March 10, 2004
Boston Millennia Partners Leads $30 Million Venture Capital Investment in CombinatoRx, Incorporated
Charlestown, MA, USA –- March 9, 2004
Dynavax to Use PHT LogPad in Three Allergy Trials
Forbes Magazine - March 01, 2004
From the Brink Of Death
Boston, Massachusetts - December 3, 2003
Boston Millennia Partners Invests in Protein Forest, Inc.
Cumberland, RI - (BUSINESS WIRE) - December 3, 2003
Collegium Pharmaceutical Signs Agreement with Endo Pharmaceuticals to Develop Abuse Deterrent Pain Products
BOSTON, MA - November 25, 2003
Boston Millennia Partners Invests in CardioMEMS, Inc.
Boston, Massachusetts - (Business Wire) – October 29, 2003
Boston Millennia Partners Invests in ArthroSurface
Cumberland, RI - October 28, 2003
Collegium Pharmaceutical raises Series A funding from Boston Millennia Partners
Charlestown, MA - October 22, 2003
PHT Technology Program Enables Clinical Trial Sponsors to Reduce Costs by 50% or More
CHARLESTOWN, MA - May 14, 2003
PHT Corporation Signals New Stage Of Growth Appointing Philip Lee As President And Chief Executive Officer
Charlestown, MA - July 9, 2001
PHT Corporation Announces Over $18 Million in Private Financing
Wayland, MA - April 2, 2001
Knowledge Impact Secures $24 Million Mezzanine Financing
|
